Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 97 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 6653309

    Inhibitors of IMPDH enzyme technical field of the invention

    Vertex Pharmaceuticals Incorporated · Granted Nov 25, 2003 · Expires Nov 20, 2023

    expired

  2. US 6653300

    Pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Nov 25, 2003 · Expires Nov 20, 2023

    expired

  3. US 6653301

    Pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Nov 25, 2003 · Expires Nov 20, 2023

    expired

  4. US 6649654

    Methods for identifying and using IKK inhibitors

    The Regents of the University of California · Granted Nov 18, 2003 · Expires Nov 13, 2023

    expired

  5. US 6649640

    Isoxazole compositions useful as inhibitors of ERK

    Vertex Pharmaceuticals Incorporated · Granted Nov 18, 2003 · Expires Nov 13, 2023

    expired

  6. US 6649643

    Imidazol-4-ylmehanols and their use as inhibitors of steroid C17-20 lyase

    Takeda Chemical Industries Ltd. · Granted Nov 18, 2003 · Expires Nov 13, 2023

    expired

  7. US 6642227

    Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Nov 4, 2003 · Expires Oct 30, 2023

    expired

  8. US 6638543

    Use of natural EGFR inhibitors to prevent side effects due to retinoid therapy, soaps, and other stimuli that activate the epidermal growth factor receptor

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 28, 2003 · Expires Oct 23, 2023

    expired

  9. US 6638926

    Pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Oct 28, 2003 · Expires Oct 23, 2023

    expired

  10. US 6635644

    Inhibitors of p38

    Vertex Pharmaceuticals Incorporated · Granted Oct 21, 2003 · Expires Oct 16, 2023

    expired

  11. US 6632945

    Inhibitors of P38

    Vertex Pharmaceuticals Incorporated · Granted Oct 14, 2003 · Expires Oct 9, 2023

    expired

  12. US 6632962

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Oct 14, 2003 · Expires Oct 9, 2023

    expired

  13. US 6632808

    Inhibitors of amyloid formation

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 14, 2003 · Expires Oct 9, 2023

    expired

  14. US 6632809

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Oct 14, 2003 · Expires Oct 9, 2023

    expired

  15. US 6630464

    Cyclin dependent kinase (CDK)4 inhibitors and their use for treating cancer

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 7, 2003 · Expires Oct 2, 2023

    expired

  16. US 6630447

    Peptide inhibitors of LFA-1/ICAM-1 interaction

    The Regents of the University of New Mexico · Granted Oct 7, 2003 · Expires Oct 2, 2023

    expired

  17. US 6624166

    Pyridazines as interleukin-1&bgr; converting enzyme inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Sep 23, 2003 · Expires Sep 18, 2023

    expired

  18. US 6617331

    Purine inhibitors of protein kinases, G proteins and polymerases

    The Regents of the University of California · Granted Sep 9, 2003 · Expires Sep 4, 2023

    expired

  19. US 6617309

    Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease

    Vertex Pharmaceuticals Incorporated · Granted Sep 9, 2003 · Expires Sep 4, 2023

    expired

  20. US 6617350

    Inhibitors of aspartyl protease

    Vertex Pharmaceuticals Incorporated · Granted Sep 9, 2003 · Expires Sep 4, 2023

    expired

  21. US 6613764

    Aspartic protease inhibitors

    The United States of America, as represented by the Department of Health and Human Services · Granted Sep 2, 2003 · Expires Aug 28, 2023

    expired

  22. US 6613743

    Sulfonamide inhibitors of aspartyl protease

    Vertex Pharmaceuticals Incorporated · Granted Sep 2, 2003 · Expires Aug 28, 2023

    expired

  23. US 6613776

    Pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Sep 2, 2003 · Expires Aug 28, 2023

    expired

  24. US 6610684

    Fused azepinone cyclin dependent kinase inhibitors

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 26, 2003 · Expires Aug 21, 2023

    expired

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.